MCID: ORL005
MIFTS: 47

Oral Candidiasis malady

Categories: Infectious diseases, Oral diseases

Aliases & Classifications for Oral Candidiasis

About this section

Aliases & Descriptions for Oral Candidiasis:

Name: Oral Candidiasis 11 50 13 68
Thrush 11 2 13
Candidiasis of Mouth 11
Candidiasis, Oral 39
 
Oral Moniliasis 11
Equine Thrush 68
Thrush, Oral 11
Candidiasis 68

Classifications:



External Ids:

Disease Ontology11 DOID:14262
ICD1030 B37.0, B37.9
ICD9CM32 112.0
MeSH39 D002180
NCIt45 C28137

Summaries for Oral Candidiasis

About this section
Disease Ontology:11 A candidiasis that involves fungal infection of the mucous membrane of the mouth by Candida species, which is characterized by thick white or cream-colored deposits on inflamed mucosal membranes.

MalaCards based summary: Oral Candidiasis, also known as thrush, is related to immunodeficiency 32b, monocyte and dendritic cell deficiency, autosomal recessive and median rhomboid glossitis, and has symptoms including oral manifestations An important gene associated with Oral Candidiasis is DEFB4A (Defensin Beta 4A), and among its related pathways are Cytokines and Inflammatory Response and Defensins. The drugs clotrimazole and fluconazole have been mentioned in the context of this disorder. Affiliated tissues include liver, kidney and bone marrow, and related mouse phenotype Increased shRNA abundance (Z-score > 2).

Wikipedia:71 Oral candidiasis, also known as oral thrush among other names, is candidiasis that occurs in the mouth.... more...

Related Diseases for Oral Candidiasis

About this section

Diseases related to Oral Candidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 90)
idRelated DiseaseScoreTop Affiliating Genes
1immunodeficiency 32b, monocyte and dendritic cell deficiency, autosomal recessive11.0
2median rhomboid glossitis10.9
3candidiasis10.8
4lipoid nephrosis10.4DEFB4A, IL1A
5optic atrophy 710.4IL1A, LTF
6lymphangiectasia, intestinal10.3CXCL8, LTF
73-alpha hydroxyacyl-coa dehydrogenase deficiency10.3CXCL8, LTF
8gallbladder lymphoma10.3CXCL8, DEFB4A
9postcricoid region cancer10.3CD4, LTF
10benign lymphoepithelial lesion of salivary gland10.3IL1A, LTF
11cantalamessa baldini ambrosi syndrome10.2HTN3, SKAP2
12chronic conjunctivitis10.2CD4, SKAP2
13chronic hiccups10.2CD4, IL1A
14small intestine leiomyoma10.2CD4, IL1A
15orbital lymphangioma10.2CXCL8, IL1A
16inhalation anthrax10.1CD4, CXCL8
1710.1CXCL8, IL1A
18ocular cancer10.1CD4, CXCL8
19subacute monocytic leukemia10.1DEFB4A, IL1A
20leukoplakia10.1
21enamel caries10.1LTF, MUC7
22skin melanoma10.1CD4, DEFB4A, LTF
23sinusitis10.1CXCL8, IL1A
24abnormal threshold of rods10.1B2M, SKAP2
25kidney angiomyolipoma10.1CD4, CXCL8
26lesion of sciatic nerve10.1B2M, SKAP2
27vaginitis10.1CD4, CXCL8
28spastic entropion10.1CXCL8, LTF
29neonatal period electroclinical syndrome10.1CXCL8, IL1A
30geotrichosis10.0CD4, CXCL8
31common cold10.0CXCL8, IL1A
32scrotum basal cell carcinoma10.0CD4, DEFA1, DEFB4A
33uterus carcinoma in situ10.0CXCL8, DEFB4A, IL1A
34accessory nerve disease10.0CXCL8, DEFB4A, IL1A
35nervous system cancer10.0CXCL8, DEFB4A, IL1A
36palmoplantar keratosis10.0CXCL8, DEFB4A, IL1A
37biliary tract disease10.0CD4, CXCL8
38oral hairy leukoplakia10.0
39pseudoretinitis pigmentosa9.9CXCL8, IL1A, LTF
40inflammatory spondylopathy9.9CD4, CXCL8, DEFB4A
41gonadal dysgenesis9.9B2M, CD4
42primary biliary cirrhosis9.9B2M, IL1A
43papillary transitional carcinoma9.9CD4, DEFA1, IL1A
44lymphangioma9.9CXCL8, IL1A
45gastric hemangioma9.8B2M, CXCL8
46rh isoimmunization9.8B2M, CD4
47leukemia9.8
48lung sarcoma9.8CD4, CXCL8, IL1A
49xanthomatosis9.8CD4, CXCL8, IL1A
50hiv-19.8

Comorbidity relations with Oral Candidiasis via Phenotypic Disease Network (PDN):

(show all 37)
Acquired ThrombocytopeniaActive Peptic Ulcer Disease
Acute CystitisAcute Kidney Failure
Alzheimer DiseaseAnxiety Disorder
BronchitisBronchopneumonia
Chronic Pulmonary Heart DiseaseCoronary Artery Disease
Cushing's SyndromeDecubitus Ulcer
Deficiency AnemiaDysthymic Disorder
Esophageal CandidiasisEsophagitis
Familial Atrial FibrillationGlossitis
Heart DiseaseHypertension, Essential
HypothyroidismIron Deficiency Anemia
Ischemic Heart DiseaseNeutropenia
OsteoporosisParalytic Ileus
Peripheral Vascular DiseasePharyngitis
PneumocystosisPostinflammatory Pulmonary Fibrosis
Protein-Energy MalnutritionRespiratory Failure
Rheumatoid ArthritisSchizophreniform Disorder
Status AsthmaticusSwallowing Disorders
Vulvovaginal Candidiasis

Graphical network of the top 20 diseases related to Oral Candidiasis:



Diseases related to oral candidiasis

Symptoms & Phenotypes for Oral Candidiasis

About this section

UMLS symptoms related to Oral Candidiasis:


oral manifestations

GenomeRNAi Phenotypes related to Oral Candidiasis according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00366-A-359.3CD4, DEFA1, DEFB4A

Drugs & Therapeutics for Oral Candidiasis

About this section

Drugs for Oral Candidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 145)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
FluconazoleapprovedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 117886386-73-43365
Synonyms:
2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-difluoro-,1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL
2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
2-(2,4-Difluoro-phenyl)-1,3-bis-[1,2,4]triazol-1-yl-propan-2-ol
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol
2-(2,4-Difluorophenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol
2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
86386-73-4
AC-428
AC1L1FRQ
AC1Q77FV
AKOS000280854
AbZ Brand of Fluconazole
Afungil
Alflucoz
Aliud Brand of Fluconazole
Alpharma Brand of Fluconazole
Apo Fluconazole
Apo-Fluconazole
Apotex Brand of Fluconazole
Armstrong Brand of Fluconazole
BIDD:GT0799
BRD-K05977355-001-02-6
BSPBio_003504
Baten
Beagyne
Bio-0041
Biocanol
Biozole
Biozolene
C13H12F2N6O
CCRIS 7211
CHEBI:46081
CHEMBL106
CID3365
CPD000471882
Canzol
Chemia Brand of Fluconazole
Cryptal
D00322
D015725
DB00196
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER
DIFLUCAN IN SODIUM CHLORIDE 0.9%
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
DRG-0005
Diflazon
Diflucan
Diflucan (TN)
Diflucan, Trican, Alfumet, Fluconazole
Dimycon
DivK1c_001030
Effik Brand of Fluconazole
Elazor
F0677
F8929_SIGMA
FCZ
FLCZ
Fluc Hexal
Flucazol
FlucoLich
Flucobeta
Fluconazol
Fluconazol AL
Fluconazol AbZ
Fluconazol Isis
Fluconazol Stada
Fluconazol [Spanish]
Fluconazol ratiopharm
Fluconazol von ct
Fluconazol-Isis
Fluconazol-ratiopharm
Fluconazole & Bovine Lactoferrin
Fluconazole & Human recombinant granulocyte colony stimulating factor
Fluconazole & MC-510,011
Fluconazole & hGCSF
Fluconazole (JAN/USAN/INN)
Fluconazole [USAN:INN:BAN:JAN]
Fluconazole in combination with MGCD290
Fluconazole in dextrose 5% in plastic container
Fluconazole in sodium chloride 0.9%
Fluconazole in sodium chloride 0.9% in plastic container
Fluconazolum
Fluconazolum [Latin]
Flucostat
 
Flucytosine & Nyotran
Flucytosine & Nyotran(Liposomal Nystatin)
Flukezol
Flunazul
Flunizol
Fluzone
Forcan
Fuconal
Fungata
GL663142 & Fluconazole
HMS1922O10
HMS2090I20
HMS2093M21
HMS503M21
HSDB 7420
Hexal Brand of Fluconazole
I06-0069
IDI1_001030
KBio1_001030
KBio2_002134
KBio2_004702
KBio2_007270
KBio3_003009
KBioGR_000360
KBioSS_002134
KS-1059
LS-1858
Lavisa
Lesvi Brand of Fluconazole
Lichtenstein Brand of Fluconazole
Loitin
MLS001066394
MLS001165780
MLS001195645
MLS001304713
MLS001306492
Mack Brand of Fluconazole
MolPort-000-883-859
MolPort-002-885-825
Mutum
NCGC00095089-01
NCGC00095089-02
NCGC00095089-04
NCGC00095089-05
NINDS_001030
Neofomiral
Oxifugol
Oxifungol
Pfizer Brand of Fluconazole
Pfleger Brand of Fluconazole
Pritenzol
S1331_Selleck
SAM002589905
SAT Brand of Fluconazole
SMR000471882
SPBio_001613
SPECTRUM1503975
STK619301
Silanes Brand of Fluconazole
Solacap
Spectrum2_001607
Spectrum3_001912
Spectrum4_000090
Spectrum5_001277
Spectrum_001654
Stada Brand of Fluconazole
Syscan
TL8005609
TPF
Triflucan
UK 49858
UK-49858
UK49858
UNII-8VZV102JFY
Vita Brand of Fluconazole
XMP.284 & Fluconazole
XMP.366 & Fluconazole
XMP.391 & Fluconazole
ZINC00004009
Zemyc
Zoltec
Zonal
betapharm Brand of Fluconazole
ct Arzneimittel Brand of Fluconazole
ct-Arzneimittel Brand of Fluconazole
fluconazole
nchembio.100-comp3
nchembio.65-comp15
ratiopharm Brand of Fluconazole
2
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
3
Voriconazoleapproved, investigationalPhase 4, Phase 3, Phase 2127137234-62-971616
Synonyms:
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
137234-62-9
173967-54-9
AC-823
AC1L2GHR
AC1Q4O6I
AKOS005145705
C07622
C102790
CHEBI:10023
CHEMBL638
CID71616
CPD000466350
D00578
DB00582
DRG-0301
FT-0082604
HMS2051N09
LS-181799
 
MLS000759464
MLS001424082
MolPort-003-850-863
Pfizer brand of voriconazole
S1442_Selleck
SAM001246664
SMR000466350
TL8000858
UK 109,496
UK 109496
UK-109,496
UK-109496
UNII-JFU09I87TR
VCZ
VRC
Vfend
Vfend (TN)
Vfend, Voriconazole
Voriconazol
Voriconazole
Voriconazole (JAN/USAN/INN)
Voriconazole [USAN:INN:BAN]
Voriconazole in combination with MGCD290
Voriconazolum
ZINC00014864
voriconazole
4
Anidulafunginapproved, investigationalPhase 4, Phase 338166663-25-8166548
Synonyms:
(4R,5R)-4,5-Dihydroxy-N(sup 2)-((4'-(pentyloxy)-p-terphenyl-4-yl)carbonyl)-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6-1)-peptide
(4R,5R)-4,5-Dihydroxy-N²-[[4''-(pentyloxy)-p-terphenyl-4-yl]carbonyl]-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6->1)-peptide
166663-25-8
AC1L4YAI
Anidulafungin
Anidulafungin [USAN:INN]
Anidulafungina
Anidulafungine
Anidulafunginum
CHEBI:55346
 
CID166548
DB00362
Ecalta
Echinocandin B, 1-((4R,5R)-4,5-dihydroxy-N2-((4"-(pentyloxy)(1,1':4',1"-terphenyl)-4-yl)carbonyl)-L-ornithine)
Eraxis
LS-63738
LY-303366
N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.09,13]heptacosan-18-yl]- 4-{4-[4-(pentyloxy)phenyl]phenyl}benzamide
N-{(2R,6S,9S,11R,12R,14aS,15S,16S,20S,23S,25aS)-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6,20-bis[(1R)-1-hydroxyethyl]-16-methyl-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl}-4''-(pentyloxy)-1,1':4',1''-terphenyl-4-carboxamide
UNII-9HLM53094I
V-Echinocandin
VER-002
5
TerconazoleapprovedPhase 4, Early Phase 1867915-31-5441383
Synonyms:
1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine
1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
1-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
1-[4-[[(4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
1-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine
67915-31-5
85058-79-3
AB00513849
AC1L1895
AC1L1KA5
AC1L9B2M
AC1LA3NV
AC1Q3MYQ
AC1Q3N0B
AR-1I2364
AR-1L5963
BIDD:GT0705
BPBio1_000429
BRD-K86204871-001-02-2
BSPBio_000389
C08080
C26H31Cl2N5O3
CAS-67915-31-5
CHEMBL1306
CID441383
CID480953
CID50001
CID5404
CID9936883
D00888
DB00251
EINECS 267-751-6
Fungistat
Gyno-Terazol
HMS1569D11
LS-176634
MLS002153844
 
MLS002701820
NCGC00016912-01
NCGC00179575-01
NSC 331942
NSC331942
Piperazine, 1-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(1-methylethyl)-, rel-(2R,4S)
Prestwick0_000495
Prestwick1_000495
Prestwick2_000495
Prestwick3_000495
Prestwick_812
R 42,470
R 42470
R-42470
SMR001233206
SMR001565413
SPBio_002310
Terazol
Terazol 3
Terazol 3 (TN)
Terazol 7
Terazol 7 3
Terazol 7 & 3
Terazol Cream & Suppositories
Terconazol
Terconazol [INN-Spanish]
Terconazole (USAN/INN)
Terconazole [USAN:INN:BAN]
Terconazolum
Terconazolum [INN-Latin]
Tercospor
Tetrazol 3
Tetrazol 7
Triaconazole
UNII-0KJ2VE664U
Zazole
cis-1-(p-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-isopropylpiperazine
nchembio.154-comp19
terconazole
6
Clotrimazoleapproved, vet_approvedPhase 4, Phase 3, Phase 23523593-75-12812
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(o-Chloro-α,α-diphenylbenzyl)imidazole
1-(o-Chlorotrityl)imidazole
1-(α-(2-Chlorophenyl)benzhydryl)imidazole
117829-71-7
23593-75-1
33894_FLUKA
33894_RIEDEL
3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591
AB00051951
AC-279
AC1L1EIW
B 5097
BAY 5097
BAY b 5097
BAY b5097
BAY-5097
BAYb 5097
BIDD:GT0450
BIDD:PXR0036
BPBio1_000126
BRN 0622318
BSPBio_000114
BSPBio_002057
Bay b 9057
Bay-B 5097
Bayer Brand 1 of Clotrimazole
Bayer Brand 2 of Clotrimazole
Bio-0442
C 6019
C06922
C22H17ClN2
C6019_SIGMA
CAS-23593-75-1
CCRIS 6245
CHEBI:3764
CHEMBL104
CID2812
CPD-8926
CPD000058306
Canesten
Canesten 1-Day Cream Combi-Pak
Canesten 1-Day Therapy
Canesten 3-Day Therapy
Canesten 6-Day Therapy
Canesten Combi-Pak 1-Day Therapy
Canesten Combi-Pak 3-Day Therapy
Canesten Cream
Canesten Solution
Canestene
Canestine
Canifug
Chlotrimazole
Cimitidine
Clomatin
Clotrimaderm
Clotrimaderm Cream
Clotrimazol
Clotrimazol [INN-Spanish]
Clotrimazole
Clotrimazole (JP15/USP/INN)
Clotrimazole Schering Brand
Clotrimazole [USAN:INN:BAN:JAN]
Clotrimazolum
Clotrimazolum [INN-Latin]
Cutistad
D00282
D003022
DB00257
DRG-0072
Desamix F
DivK1c_000665
EINECS 245-764-8
EU-0100315
Empecid
Esparol
FB 5097
FB b 5097
Fem Care
FemCare
Gino-Lotremine
Gyne lotrimin
Gyne-Lotrimin
Gyne-Lotrimin 3
Gyne-Lotrimin 3 Combination Pack
Gyne-Lotrimin Combination Pack
Gyne-Lotrimin3
Gyne-Lotrimin3 Combination Pack
Gyne-lotrimin
Gynix
HMS1568F16
HMS1920O21
HMS2051E11
HMS2091G10
HMS502B07
HSDB 3266
I01-3474
IDI1_000665
 
KBio1_000665
KBio2_001823
KBio2_004391
KBio2_006959
KBio3_001277
KBioGR_000850
KBioSS_001823
Kanesten
Klotrimazole
LS-78271
Lopac-C-6019
Lopac0_000315
Lotrimax
Lotrimin
Lotrimin (TN)
Lotrimin (tn)
Lotrimin AF
Lotrimin AF Cream
Lotrimin AF Jock-Itch Cream
Lotrimin AF Lotion
Lotrimin AF Solution
Lotrimin Af
Lotrimin Cream
Lotrimin Lotion
Lotrimin Solution
Lotrisone
MLS000028502
MLS000758243
MLS001423972
MolPort-002-557-756
Mono-baycuten
Monobaycuten
Mycelax
Mycelex
Mycelex (TN)
Mycelex (tn)
Mycelex 7
Mycelex Cream
Mycelex G
Mycelex OTC
Mycelex Solution
Mycelex Troches
Mycelex Twin Pack
Mycelex-7
Mycelex-7 Combination Pack
Mycelex-G
Mycelex: MycosporinRimazole
Myclo Cream
Myclo Solution
Myclo Spray Solution
Myclo-Gyne
Mycofug
Mycosporin
Mykosporin
NCGC00015251-01
NCGC00015251-02
NCGC00015251-03
NCGC00015251-09
NCGC00093761-01
NCGC00093761-02
NCGC00093761-03
NCGC00093761-04
NCGC00093761-05
NCGC00093761-06
NCIMech_000609
NINDS_000665
NSC 257473
NSC257473
Nalbix
Neo-Zol Cream
Otomax
Pan-Fungex
Pedisafe
Prestwick0_000267
Prestwick1_000267
Prestwick2_000267
Prestwick3_000267
Prestwick_120
QTL1_000024
Rimazole
S1606_Selleck
SAM001247056
SMR000058306
SPBio_000176
SPBio_002333
SPECTRUM1500200
STK700023
Schering Brand of Clotrimazole
Spectrum2_000128
Spectrum3_000359
Spectrum4_000295
Spectrum5_000781
Spectrum_001343
Stiemazol
Tibatin
Trimysten
Trivagizole 3
UNII-G07GZ97H65
Veltrim
ZINC03807804
clotrimazole
clotrimeizol
nchembio.65-comp9
nchembio790-comp30
7
Epinephrineapproved, vet_approvedPhase 493351-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
8
Itraconazoleapproved, investigationalPhase 4, Phase 3, Phase 114784625-61-655283
Synonyms:
(+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one
(+/-)-1-[( R *)- sec -butyl]-4-[ p -[4-[ p -[[(2 R *,4 S *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-(DELTA) 2 1,2,4-triazolin-5-one mixture with (+/-)-1-[( R *)- sec -butyl]-4-[ p -[4- [ p -[[(2 S *,4 R *)-2-(2,4-dichlorophenyl)-2-(1 H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl] phenyl]-(DELTA) 2 -1,2,4-triazolin-5-one
(1)-cis-4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2,4-dihydro-2-sec-butyl-3H-1,2,4-triazol-3-one
2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)
4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
84604-65-9
84625-61-6
AC-542
AC1L1GQ5
AC1L1IRU
AC1OCEL7
AC1Q6EZ3
AKOS000280875
Ambap84625-61-6
BIDD:GT0796
BRN 6042047
C35H38Cl2N8O4
CHEBI:6076
CHEMBL22587
CHEMBL882
CID3793
CID55283
CID6917738
CID9961741
CPD000058959
Canadiol
D00350
DB01167
EINECS 283-347-2
FT-0082511
HMS2051K14
HMS2090M20
Hyphanox
I01-1043
I0732
ITC
ITCZ
ITZ
Intraconazole
 
Itraconazol
Itraconazol [Spanish]
Itraconazole
Itraconazole & Bovine Lactoferrin
Itraconazole & Nyotran
Itraconazole & Nyotran(Liposomal Nystatin)
Itraconazole (JAN/USAN)
Itraconazole [USAN:BAN:INN:JAN]
Itraconazole oral solution
Itraconazolum
Itraconazolum [Latin]
Itrizole
Itrizole (TN)
Itrizole (tn)
LS-1843
MLS000028582
MLS000759472
MLS000863291
MLS001148245
MolPort-000-883-864
MolPort-003-848-295
NCGC00089812-03
Oriconazole
Oriconazole, R51211, Sporanox
Orungal
Prokanazol
R 51211
R-51211
S2476_Selleck
SAM001246679
SMR000058959
Sempera
Spherazole
Sporal
Sporanos
Sporanox
Sporanox (TN)
Sporanox (tn)
Sporonox
TL8005525
Triasporn
UNII-304NUG5GF4
cis-Itraconazole
itraconazole
9
Nystatinapproved, vet_approvedPhase 4, Phase 3, Phase 2411400-61-911953884
Synonyms:
(1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-a-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
(1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-[(3-amino-3,6-dideoxy-alpha-D-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid
(4E,6E,8E,10E,14E,16E)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
(4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,35S)-3-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
(4E,6E,8E,10E,14E,16E,18S,19R,21S,35S)-3-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14,16-hexaene-38-carboxylic acid
AC1NSKG2
AC1NWAPF
AC1O5FWI
AI3-26526
BCBcMAP01_000244
BSPBio_002119
Barstatin 100
Biofanal
C47H75NO17
CHEBI:473992
CHEMBL1200650
CHEMBL229383
CID5311331
CID5702099
CID6433272
Candex Lotion
Candio-hermal
Caswell No. 607B
Comycin
Diastatin
EINECS 215-749-0
EPA Pesticide Chemical Code 202800
Fungicidin
HMS1920D08
HMS2091L08
HMS500N05
HSDB 3138
Herniocid
IDI1_000263
Korostatin
LS-187914
LS-97612
MolPort-003-665-538
MolPort-003-938-857
MolPort-003-983-447
Moronal
Moronal (antibiotic)
Myconystatin
Mycostatin
Mycostatin 20
 
Mycostatin Pastilles
Mykinac
Mykostatyna
N1638_SIGMA
N3503_SIGMA
N4014_SIGMA
N6261_SIGMA
NSC 150817
NYS
Nilstat
Nistatin
Nistatina
Nistatina [INN-Spanish]
Nyamyc
Nyotran
Nystaform
Nystan
Nystatin
Nystatin A
Nystatin A1
Nystatin A1, A2, A3 complex
Nystatin A2
Nystatin A3
Nystatin G
Nystatin LF (liposome)
Nystatin [INN:BAN:JAN]
Nystatin preparation
Nystatine
Nystatine [INN-French]
Nystatinum
Nystatinum [INN-Latin]
Nystatyna
Nystatyna [Polish]
Nystavescent
Nystex
Nystop
O-V Statin
SMP1_000219
SPECTRUM1500446
Spectrum5_001333
Stamicin
Stamycin
Terrastatin
UNII-BDF1O1C72E
UNII-ZGT9EY838C
Zydin E
nystatin
10
Mycophenolic acidapprovedPhase 493924280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
11
Mycophenolate mofetilapproved, investigationalPhase 4939128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
12
Prednisoneapproved, vet_approvedPhase 4135953-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
13Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13822
14Cytochrome P-450 CYP2C9 InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 1658
15Adrenergic AgentsPhase 4, Phase 35140
16Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Early Phase 110884
17Antifungal AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 13615
18Antibiotics, AntitubercularPhase 4, Phase 36972
19Steroid Synthesis InhibitorsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11718
20Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 121402
21Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210355
22Autonomic AgentsPhase 4, Phase 3, Phase 29774
23Bronchodilator AgentsPhase 4, Phase 32856
24Dermatologic AgentsPhase 4, Phase 35674
25Anti-Asthmatic AgentsPhase 4, Phase 33369
26Anti-Allergic AgentsPhase 4, Phase 31490
27Adrenergic AgonistsPhase 4, Phase 32877
28Adrenergic beta-2 Receptor AgonistsPhase 4, Phase 3925
29Adrenergic beta-AgonistsPhase 4, Phase 31640
30
Salmeterol xinafoatePhase 4, Phase 335094749-08-356801
Synonyms:
(+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol 1-hydroxy-2-naphthoate (salt)
(+/-) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-, 1-hydroxy-2-naphthalenecarboxylate (salt)
1-hydroxynaphthalene-2-carboxylic acid
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
89365-50-4 (Parent)
94749-08-3
AC1L1LPS
Arial
Asmerole
Beglan
Betamican
Bio-0096
C25H37NO4.C11H8O3
CHEMBL1082607
CID56801
D00687
Dilamax
EU-0101100
GR 33343 G
GR 33343X xinafoate
 
GR-33343 G
Inaspir
LS-94516
MLS001332577
MLS001332578
MolPort-003-850-218
NCGC00094372-01
NCGC00094372-02
NCGC00094372-03
NCGC00094372-04
S5068_SIGMA
SMR000875207
Salmetedur
Salmeterol 1-hydroxy-2-naphthoate
Salmeterol xinafoate (JAN/USAN)
Salmeterol xinafoate [USAN]
Serevent (TN)
Serevent Inhaler and Disks
Serevent diskus
UNII-6EW8Q962A5
Ultrabeta
salmeterol xinafoate
31
FluticasonePhase 4, Phase 363090566-53-3, 80474-14-262924, 22833648
Synonyms:
90566-53-3
AC-456
AC1NSJZT
Asmatil
Axotide
BIDD:GT0819
Brethal
C07815
CHEMBL1201396
CID5311101
Cultivate
Cutivate
D07981
Flixonase
Flixonase Nasal Spray
Flixotide
Flixotide Disk
 
Flixotide Disks
Flixotide Inhaler
Flonase
Flovent
Flovent Diskus
Flovent Rotadisk
Fluinol
Flunase
Flusonal
Fluspiral
Fluticaps
Fluticaps (TN)
Fluticasone (INN)
Fluticasonpropionat Allen
Flutide
Flutivate
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
fluticasone
32Fluticasone Propionate, Salmeterol Xinafoate Drug CombinationPhase 4, Phase 3201
33Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 222776
34Respiratory System AgentsPhase 4, Phase 34818
35Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 112767
36Neurotransmitter AgentsPhase 4, Phase 3, Phase 217734
37HormonesPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 113979
38glucocorticoidsPhase 4, Phase 3, Phase 24920
39Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 112778
40
s 1 (combination)Phase 4364
Synonyms:
 
Gimeracil / oteracil / tegafur
TS 1
41Sodium hypochloritePhase 442
42Antitubercular AgentsPhase 4, Phase 31272
43RacepinephrinePhase 4933
44HydroxyitraconazolePhase 4, Phase 3, Phase 1147
45DisinfectantsPhase 4547
46Anti-Infective Agents, LocalPhase 4, Phase 31785
47Cytochrome P-450 CYP3A InhibitorsPhase 4, Phase 3, Phase 2, Phase 11666
48Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27793
49IonophoresPhase 4, Phase 348
50EchinocandinsPhase 4, Phase 3, Phase 2123

Interventional clinical trials:

(show top 50)    (show all 110)
idNameStatusNCT IDPhase
1Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BIDUnknown statusNCT00235053Phase 4
2Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a WeekUnknown statusNCT00537888Phase 4
3A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent ThrushCompletedNCT00000951Phase 4
4Fluconazole Prophylaxis of Thrush in AIDSCompletedNCT00001542Phase 4
5Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in TanzaniaCompletedNCT00553137Phase 4
6This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4
7Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisCompletedNCT00496197Phase 4
8Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal CandidiasisCompletedNCT02180828Phase 4
9Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal CandidiasisCompletedNCT02180100Phase 4
10Antifungal Prophylaxis in Intensive Care Unit (ICU) PatientsCompletedNCT01495039Phase 4
11A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal InfectionsCompletedNCT00647907Phase 4
12Effectiveness of Hygiene Solutions on Denture BiofilmCompletedNCT02407834Phase 4
13Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) PatientsTerminatedNCT01282879Phase 4
14RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean SectionWithdrawnNCT02009098Phase 4
15Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive PatientsCompletedNCT00002446Phase 3
16A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal CandidiasisCompletedNCT00128323Phase 3
17Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisCompletedNCT00666185Phase 3
18Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedNCT00665639Phase 3
19Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal CandidiasisCompletedNCT02184351Phase 3
20Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal AntisepticCompletedNCT02818803Phase 3
21A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2CompletedNCT00001812Phase 3
22Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal CandidiasisCompletedNCT01427738Phase 3
23Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer PatientsCompletedNCT00168181Phase 3
24Effect of Probiotic Lozenge on Gingivitis and PeriodontitisCompletedNCT02203812Phase 3
25Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic ChemotherapyCompletedNCT00152867Phase 3
26Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety StudyCompletedNCT01018186Phase 3
27Prophylactic Antibiotics in MeaslesCompletedNCT00168532Phase 3
28Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaCompletedNCT02175771Phase 3
29Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator TherapyCompletedNCT02181335Phase 3
30Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3
31A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune SystemsCompletedNCT00002339Phase 3
32The Study Of Fluconazole For Vulvovaginal CandidiasisCompletedNCT01806623Phase 3
33Diabetes Mellitus and Vulvovaginal CandidiasisCompletedNCT00353561Phase 3
34A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.CompletedNCT00163111Phase 3
35A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal InfectionCompletedNCT00784368Phase 3
36The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisCompletedNCT00056368Phase 3
37Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)CompletedNCT00034632Phase 3
38Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams BirthweightCompletedNCT00734539Phase 3
39Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV PatientsCompletedNCT00390780Phase 3
40Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant PatientsCompletedNCT00001937Phase 3
41Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal DischargeCompletedNCT02111629Phase 3
42Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisRecruitingNCT00761267Phase 3
43A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric PatientsTerminatedNCT01092832Phase 3
44A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisTerminatedNCT01176058Phase 3
45Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral CandidiasisCompletedNCT00659971Phase 2
46A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With FluconazoleCompletedNCT00001065Phase 2
47Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of TrochesCompletedNCT00835029Phase 2
48A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive PatientsCompletedNCT00002399Phase 2
49Quaternary Ammonium Methacryloxy Silicate-containing Acrylic ResinCompletedNCT02525458Phase 2
50Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal CandidiasisCompletedNCT01926028Phase 1, Phase 2

Search NIH Clinical Center for Oral Candidiasis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: candidiasis, oral

Genetic Tests for Oral Candidiasis

About this section

Anatomical Context for Oral Candidiasis

About this section

MalaCards organs/tissues related to Oral Candidiasis:

36
Liver, Kidney, Bone marrow, Salivary gland, Colon, Bone, Tongue

Publications for Oral Candidiasis

About this section

Articles related to Oral Candidiasis:

(show top 50)    (show all 404)
idTitleAuthorsYear
1
Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern. (27403171)
2016
2
Oral candidiasis following steroid therapy for oral lichen planus. (26599999)
2016
3
Elimination of oral candidiasis may increase stimulated whole salivary flow rate. (27497081)
2016
4
Prevention of Oral Candidiasis After Free Flap Surgery: Role of 3% Sodium Bicarbonate Saline in Oral Care. (27669373)
2016
5
Oral candidiasis. (27343964)
2016
6
Plasma Levels of IFN-I^, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis. (27127595)
2016
7
Quantification of oral palatine Langerhans cells in HIV/AIDS associated oral Kaposi sarcoma with and without oral candidiasis. (27461637)
2016
8
FACTORS RELATED TO ORAL CANDIDIASIS IN ELDERLY USERS AND NON-USERS OF REMOVABLE DENTAL PROSTHESES. (27007560)
2016
9
Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. (27042008)
2016
10
Development and evaluation of N-naphthyl-N,O-succinyl chitosan micelles containing clotrimazole for oral candidiasis treatment. (27050629)
2016
11
Molecular analysis of fungal populations in patients with oral candidiasis using next-generation sequencing. (27305838)
2016
12
Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. (27358561)
2016
13
Elucidating the Role of Hyposalivation and Autoimmunity in Oral Candidiasis. (27998016)
2016
14
Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. (26932256)
2016
15
Treatment of Oral Candidiasis Using PhotodithazineAr- Mediated Photodynamic Therapy In Vivo. (27253525)
2016
16
Topical Antimycotics for Oral Candidiasis in Warfarin Users. (27901310)
2016
17
The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial. (27977721)
2016
18
Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective study. (26481235)
2015
19
Fabrication of mucoadhesive chitosan coated polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for oral candidiasis. (26256338)
2015
20
Anti-Candida activity of aroma candy and its protective activity against murine oral candidiasis. (25855024)
2015
21
Age-related alteration of expression and function of TLRs and NK activity in oral candidiasis. (25704085)
2015
22
Does scientific evidence for the use of natural products in the treatment of oral candidiasis exist? A systematic review. (25883668)
2015
23
Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis. (26596951)
2015
24
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan. (26148537)
2015
25
Fabrication of a novel scaffold of clotrimazole-microemulsion-containing nanofibers using an electrospinning process for oral candidiasis applications. (25543979)
2015
26
Direct Microscopy: A Useful Tool to Diagnose Oral Candidiasis in Children and Adolescents. (26329143)
2015
27
C/EBPI^ Promotes Immunity to Oral Candidiasis through Regulation of I^-Defensins. (26317211)
2015
28
Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels. (25682023)
2015
29
Innovation of natural essential oil-loaded Orabase for local treatment of oral candidiasis. (26170621)
2015
30
Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis. (26719641)
2015
31
Human immunodeficiency virus induced oral candidiasis. (26538978)
2015
32
Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease. (25422264)
2015
33
Evaluation of effect of topical ozone therapy on salivary Candidal carriage in oral candidiasis. (26096109)
2015
34
The changing role of HIV-associated oral candidiasis in the era of HAART. (25868223)
2015
35
In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis. (26416861)
2015
36
Novel aggregation properties of Candida albicans secreted aspartyl proteinase Sap6 mediates virulence in oral candidiasis. (25870228)
2015
37
Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. (26456226)
2015
38
Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities. (25819801)
2015
39
Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy-era. A literature analysis. (25156369)
2014
40
Protection of mice from oral Candidiasis by heat-killed enterococcus faecalis, possibly through its direct binding to Candida albicans. (24682096)
2014
41
Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. (25169007)
2014
42
Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253. (24903939)
2014
43
Comparison of the efficacy of a novel sustained release clotrimazole varnish and clotrimazole troches for the treatment of oral candidiasis. (24867230)
2014
44
Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriers. (25201119)
2014
45
Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene. (25344377)
2014
46
Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital. (25432363)
2014
47
Immunology of oral candidiasis. (25210393)
2014
48
Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasis. (24752272)
2014
49
Fast-acting clotrimazole composited PVP/HPI^CD nanofibers for oral candidiasis application. (24554117)
2014
50
Essential oil of Melaleuca alternifolia for the treatment of oral candidiasis induced in an immunosuppressed mouse model. (25510285)
2014

Variations for Oral Candidiasis

About this section

Expression for genes affiliated with Oral Candidiasis

About this section
Search GEO for disease gene expression data for Oral Candidiasis.

Pathways for genes affiliated with Oral Candidiasis

About this section

Pathways related to Oral Candidiasis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5CD4, IL1A
2
Show member pathways
9.3CD4, DEFA1, DEFB4A
3
Show member pathways
8.7CXCL8, IL1A, IRF8
48.7CXCL8, IL1A, IRF8
5
Show member pathways
7.0B2M, CD4, DEFA1, DEFB4A, IL1A, IRF8

GO Terms for genes affiliated with Oral Candidiasis

About this section

Cellular components related to Oral Candidiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Golgi lumenGO:00057969.4DEFA1, DEFB4A, MUC7
2extracellular spaceGO:00056158.4B2M, CXCL8, DEFA1, DEFB4A, IL1A, LTF
3extracellular regionGO:00055768.2B2M, CXCL8, DEFA1, DEFB4A, HTN3, IL1A

Biological processes related to Oral Candidiasis according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1defense response to fungusGO:005083210.4DEFA1, HTN3
2killing of cells of other organismGO:003164010.3DEFA1, HTN3
3innate immune response in mucosaGO:000222710.3DEFA1, LTF
4positive regulation of interleukin-2 biosynthetic processGO:004508610.0CD4, IL1A
5chemotaxisGO:000693510.0CXCL8, DEFA1, DEFB4A
6defense response to Gram-positive bacteriumGO:00508309.8B2M, DEFA1, DEFB4A
7antibacterial humoral responseGO:00197319.8B2M, DEFA1, LTF
8regulation of defense response to virus by virusGO:00506909.8B2M, CD4
9response to molecule of bacterial originGO:00022379.8B2M, CXCL8
10defense response to bacteriumGO:00427429.7DEFB4A, HTN3, IRF8
11defense response to Gram-negative bacteriumGO:00508299.7B2M, CD4, DEFB4A
12retina homeostasisGO:00018959.5B2M, LTF
13cellular response to lipopolysaccharideGO:00712229.2B2M, CXCL8, IRF8
14immune responseGO:00069558.0CD4, CXCL8, DEFA1, DEFB4A, IL1A, IRF8

Sources for Oral Candidiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet